Besse B - Search Results

1

Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE.

Wislez M, Barlesi F, Besse B, Mazières J, Merle P, Cadranel J, Audigier-Valette C, Moro-Sibilot D, Gautier-Felizot L, Goupil F, Renault A, Quoix E, Souquet PJ, Madroszyck A, Corre R, Pérol D, Morin F, Zalcman G, Soria JC. Wislez M, et al. Among authors: besse b. J Clin Oncol. 2014 Apr 20;32(12):1256-61. doi: 10.1200/JCO.2013.53.1525. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24638013 Clinical Trial.

2

Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer.

Besse B, Candé C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G. Besse B, et al. Clin Cancer Res. 2004 Sep 1;10(17):5665-9. doi: 10.1158/1078-0432.CCR-04-0415. Clin Cancer Res. 2004. PMID: 15355891

3

[Predicting response to Iressa: unexpected mechanism].

Besse B, Le Chevalier T, Soria JC. Besse B, et al. Med Sci (Paris). 2004 Aug-Sep;20(8-9):750-1. doi: 10.1051/medsci/2004208-9750. Med Sci (Paris). 2004. PMID: 15361339 Free article. French. No abstract available.

4

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC. Erman M, et al. Among authors: besse b. Lung Cancer. 2005 Mar;47(3):315-23. doi: 10.1016/j.lungcan.2004.08.015. Lung Cancer. 2005. PMID: 15713515

5

[EGFR-targeted therapies: what's new?].

Vignot S, Besse B, Soria JC, Milano G, Spano JP. Vignot S, et al. Among authors: besse b. Bull Cancer. 2006 Jan;93(1):13-8. Bull Cancer. 2006. PMID: 16455501 Free article. Review. French.

6

[Neoadjuvant chemotherapy in non small cell lung cancer].

Besse B, Vignot S, Le Chevalier T. Besse B, et al. Bull Cancer. 2006 Nov;93(11):1087-92. Bull Cancer. 2006. PMID: 17145577 Free article. Review. French.

7

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S. Grenier J, et al. Among authors: besse b. Anticancer Res. 2007 Jan-Feb;27(1B):547-55. Anticancer Res. 2007. PMID: 17348440 Free article.

8

[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient].

Besse B, Soria JC. Besse B, et al. Rev Prat. 2007 Feb 28;57(4):429-40; quiz 440. Rev Prat. 2007. PMID: 17455746 Review. French. No abstract available.

9

Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.

Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC. Saintigny P, et al. Among authors: besse b. Clin Cancer Res. 2007 Aug 15;13(16):4825-31. doi: 10.1158/1078-0432.CCR-06-3061. Clin Cancer Res. 2007. PMID: 17699861

10

[Gemcitabine and non small-cell lung cancer].

Vignot S, Besse B. Vignot S, et al. Among authors: besse b. Bull Cancer. 2007;94 Spec No Actualites:S95-103. Bull Cancer. 2007. PMID: 17845978 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

582 results

Search Page